NCT02762084 2020-07-23
Trial of Patidegib Gel 2%, 4%, and Vehicle to Decrease the Number of Surgically Eligible Basal Cell Carcinomas in Gorlin Syndrome Patients
PellePharm, Inc.
Phase 2 Completed
Clinical Trials
6 trialsNCT02828111 2019-01-08
BCC
PellePharm, Inc.
Phase 2 Completed
NCT01130142 2017-03-06
A Study Evaluating IPI-926 in Combination With Gemcitabine in Patients With Metastatic Pancreatic Cancer
Infinity Pharmaceuticals, Inc.
Phase 1/2 Completed
NCT01310816 2013-12-05
A Safety and Efficacy Study of Patients With Metastatic or Locally Advanced (Unresectable) Chondrosarcoma
Infinity Pharmaceuticals, Inc.
Phase 2 Completed
NCT01609179 2012-11-14
IPI-926 Extension Protocol for Continuation of Treatment With IPI-926
Infinity Pharmaceuticals, Inc.
Phase NA Completed
NCT00761696 2012-06-21
A Phase 1 Study of IPI-926 in Patients With Advanced and/or Metastatic Solid Tumor Malignancies
Infinity Pharmaceuticals, Inc.
Phase 1 Completed